Avacta presenting new Affirmer applications at San Diego convention
Avacta Group
46.43p
14:44 02/05/24
-0.69%
-0.32p
Developer of ‘Affirmer’ biotherapeutics and reagents, Avacta Group, announced on Tuesday that its chief technology officer, Dr Matt Johnson, would be presenting at the Annual Biomarkers & Precision Medicine Congress in San Diego, being held 9-11 October.
FTSE AIM All-Share
766.96
15:00 02/05/24
n/a
n/a
Pharmaceuticals & Biotechnology
23,120.51
15:00 02/05/24
-0.16%
-38.21